Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2013
03/13/2013CN102961286A Hygienic disinfectant wet tissue and preparation method thereof
03/13/2013CN102961272A Salt mixed hair shampoo and preparation method thereof
03/13/2013CN102961250A Multi-component container and external preparation for treating acne
03/13/2013CN102960876A Daily article with anti-radiation effect
03/13/2013CN102579308B Scalp care and itching relieving shampoo made from Chinese medicinal herb shinyleaf prickly ash root
03/13/2013CN102429894B Application of fluoxetine in treatment of depigmentation disease
03/13/2013CN102349956B Compound extract for moisturizeing pathogenic dryness and relieving itching and preparation thereof
03/13/2013CN102349913B High concentration glycerol-type minoxidil tincture and preparation method thereof
03/13/2013CN102319285B External medicament for treating psoriasis and preparation method thereof
03/13/2013CN102283945B Chinese herbal medicine for treating burn
03/13/2013CN102266445B Eye protection Chinese medicinal composition with health care and treatment effects
03/13/2013CN102228540B Externally applied liquid medicine for treating burns and scalds
03/13/2013CN102225205B Tripterine nano structure lipid carrier and preparation method and application thereof
03/13/2013CN102153534B Compound with tyrosinase inhibitory activity as well as preparation method and application thereof
03/13/2013CN102091233B Traditional Chinese medicinal composition chilblain ointment for treating chilblain
03/13/2013CN102078394B Aconite extract-containing medicinal composition, preparation method and application thereof
03/13/2013CN102070605B Imatinib mesylate polymorph and pharmaceutical composition
03/13/2013CN102058727B Ceramide-containing tea seed extract and preparation method thereof
03/13/2013CN102056630B Stabilizer for lymph vessel
03/13/2013CN102048894B Traditional Chinese medicine composition for treating burn and preparation method thereof
03/13/2013CN101600724B Nk1 receptor antagonist composition
03/13/2013CN101597335B Recombined protein specially combined with fiber protein and application thereof
03/12/2013US8394930 Growth factor isoform
03/12/2013US8394817 CCR1 antagonists and methods of use therefor
03/12/2013US8394371 Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
03/12/2013US8394369 Chondrocyte therapeutic delivery system
03/12/2013US8394361 Stable surfactant compositions for suspending components
03/12/2013CA2706661C Intermediates for the preparation of lipoxin a4 analogs
03/12/2013CA2699568C Azaindoles
03/12/2013CA2619779C Use of a pde5 inhibitor for treating and preventing hypopigmentary disorders
03/12/2013CA2473927C Methods and compositions for treating polycystic ovary syndrome
03/12/2013CA2464111C Phosphonic acid compounds as inhibitors of serine proteases
03/12/2013CA2464092C Electroprocessing in drug delivery and cell encapsulation
03/12/2013CA2453561C Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
03/07/2013WO2013033602A2 Fatty acid amides, compositions and methods of use
03/07/2013WO2013033569A1 Heterocyclylamines as pi3k inhibitors
03/07/2013WO2013033520A1 A method for regulating skin pigmentation
03/07/2013WO2013033260A1 Use of hdl-related molecules to treat and prevent proinflammatory conditions
03/07/2013WO2013033167A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013WO2013033116A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013WO2013033070A1 COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS
03/07/2013WO2013032846A1 2-METHYLENE-19,23,24-TRINOR-1α-HYDROXYVITAMIN D3
03/07/2013WO2013032248A2 Composition for improving skin conditions, containing extracellular domain of human bone morphogenetic protein receptor 1a as active ingredient
03/07/2013WO2013031931A1 Chemokine receptor activity regulator
03/07/2013WO2013031403A1 Skin-lightening agent
03/07/2013WO2013031003A1 Dna repair accelerator and dna damage suppressant
03/07/2013WO2013030669A2 Treatment of inflammatory disease or disorder and compositions therefor
03/07/2013WO2013030512A1 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment
03/07/2013WO2013030459A1 Lipid composition for the prevention or treatment of skin problems
03/07/2013WO2013029525A1 Pharmaceutical composition comprising iodine polymer and glucocorticosteroid for treating dermatitis
03/07/2013WO2013029479A1 Mycophenolic acid derivative and preparation method and use thereof
03/07/2013WO2013002531A9 Pharmaceutical composition for treating scars on the skin, and method for treating scars on the skin using same
03/07/2013WO2012057895A9 Composition and method for treating wounds
03/07/2013US20130061341 Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
03/07/2013US20130060208 Wound care products
03/07/2013US20130059901 Pre-MRNA Trans-Splicing Molecule (RTM) Molecules and Their Uses
03/07/2013US20130059878 Treatment of diseases modulated by a h4 receptor agonist
03/07/2013US20130059866 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
03/07/2013US20130059857 Methods and compositions for safe and effective treatment of telangiectasia
03/07/2013US20130059853 Biaryl phosphodiesterase inhibitors
03/07/2013US20130059846 Compounds and compositions as c-kit kinase inhibitors
03/07/2013US20130059835 Heterocyclylamines as pi3k inhibitors
03/07/2013US20130059834 Pyrrolopyrazine kinase inhibitors
03/07/2013US20130059832 Compounds and compositions as c-kit kinase inhibitors
03/07/2013US20130059821 Bicyclic aryl sphingosine 1-phosphate analogs
03/07/2013US20130059820 Inositol pyrophosphates, and methods of use thereof
03/07/2013US20130059816 Compositions and methods for treatment of autoimmune and other disease
03/07/2013US20130059814 Anti-inflammatory dermatological composition comprising corticosteroids and hyaluronate fragments, and uses thereof
03/07/2013US20130059813 Treatment of dermatological conditions
03/07/2013US20130059801 Fatty acid amides, compositions and methods of use
03/07/2013US20130059800 Pyrrolobenzodiazepines used to treat proliferative diseases
03/07/2013US20130059791 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium slat of d-isoglutamyl-d-tryptophan
03/07/2013US20130059790 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field
03/07/2013US20130059785 Gene and Polypeptide Sequences
03/07/2013US20130059779 Stabilized Insulin-like Growth Factor Polypeptides
03/07/2013US20130059773 Compounds for the treatment of inflammation and neutropenia
03/07/2013US20130059021 Perfluoro(n-butylcyclohexane) compositions and uses thereof
03/07/2013US20130059019 Methods and compositions for treating inflammation of skin
03/07/2013US20130059017 Topical nitric oxide systems and methods of use thereof
03/07/2013US20130059004 Oral drug delivery system
03/07/2013US20130058985 Spray-Pumpable Composition Suitable for Topical Skin Application
03/07/2013US20130058983 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
03/07/2013US20130058980 Small molecule inhibitors of protein kinases
03/07/2013US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
03/07/2013US20130058928 Hair growth methods using fgfr3 extracellular domins
03/07/2013US20130058926 Method for alleviating and/or preventing skin reddening
03/07/2013US20130058917 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column
03/07/2013US20130058884 Herbal oil which is used in hair care and in massage and which is used in treatment of hair loss, hairlessness, and burns
03/07/2013US20130058868 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
03/07/2013DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols
03/07/2013CA2847001A1 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment
03/07/2013CA2846865A1 Use of hdl-related molecules to treat and prevent proinflammatory conditions
03/07/2013CA2846652A1 Heterocyclylamines as pi3k inhibitors
03/07/2013CA2845785A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013CA2845169A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013CA2845159A1 Compounds and compositions as c-kit kinase inhibitors
03/06/2013EP2565182A1 Novel amide derivative and use thereof as medicine
03/06/2013EP2564841A1 Use of travoprost for treating hair loss
03/06/2013EP2564839A2 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
03/06/2013EP2563376A1 Dermatological composition based on argan oil and hyaluronic acid